# Comparative Study of the Efficacy of Either Krytantek Ofteno PF® or Eliptic Ofteno PF® Plus Gaap Ofteno PF® for POAG or Ocular Hypertension.

> **NCT04702789** · PHASE4 · TERMINATED · sponsor: **Laboratorios Sophia S.A de C.V.** · enrollment: 28 (actual)

## Conditions studied

- Glaucoma, Open-Angle
- Ocular Hypertension

## Interventions

- **DRUG:** Dorzolamide-timolol-brimonidine and latanoprost
- **DRUG:** Dorzolamide-timolol and latanoprost

## Key facts

- **NCT ID:** NCT04702789
- **Lead sponsor:** Laboratorios Sophia S.A de C.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-10-19
- **Primary completion:** 2023-11-23
- **Final completion:** 2023-11-23
- **Target enrollment:** 28 (ACTUAL)
- **Why stopped:** For interests of sponsor.
- **Last updated:** 2026-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04702789

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04702789, "Comparative Study of the Efficacy of Either Krytantek Ofteno PF® or Eliptic Ofteno PF® Plus Gaap Ofteno PF® for POAG or Ocular Hypertension.". Retrieved via AI Analytics 2026-08-08 from https://api.ai-analytics.org/clinical/NCT04702789. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*